INNOPHARMAX Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 56.490 million compared to TWD 43.928 million a year ago. Operating loss was TWD 80.249 million compared to TWD 152.870 million a year ago. Net loss was TWD 86.348 million compared to TWD 161.936 million a year ago. Basic loss per share was TWD 1.23 compared to TWD 2.42 a year ago.